相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR
Yuhong Jiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors
Xiaoliang Wang et al.
ONCOGENE (2021)
GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets
Krishna Sriram et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways
Hossein Javid et al.
MOLECULAR BIOLOGY REPORTS (2020)
Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism
Lingaku Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Alex Friedlaender et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode
Wei Yan et al.
NATURE COMMUNICATIONS (2020)
Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis
Fei He et al.
CANCER MEDICINE (2020)
SP/NK-1R promotes gallbladder cancer cell proliferation and migration
Xue-Ting Deng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis
Fei Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Jeffrey H. Becker et al.
CANCER RESEARCH (2019)
The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
Agnieszka Majkowska-Pilip et al.
PHARMACEUTICS (2019)
Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies
Sun Min Lim et al.
CANCER TREATMENT REVIEWS (2018)
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
Shang-Gin Wu et al.
MOLECULAR CANCER (2018)
New Insights into Modes of GPCR Activation
Wenjing Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells
Chumei Huang et al.
THERANOSTICS (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
撤稿声明: c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells (Retraction of Vol 278, Pg 32618, 2003)
Sarah Kraus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition
Yi-Xin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Somatostatin Receptor Antagonists for Imaging and Therapy
Melpomeni Fani et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells
Terry W. Moody et al.
PEPTIDES (2017)
EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance
Shuhang Wang et al.
CANCER LETTERS (2017)
G protein-coupled receptors as promising cancer targets
Ying Liu et al.
CANCER LETTERS (2016)
Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14
Jingyi Li et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2016)
Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Aktip53 axis in pre-B acute lymphoblastic leukemia cells
Samaneh Bayati et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer
Shuhang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation
Georgios Kallifatidis et al.
MOLECULAR CANCER RESEARCH (2016)
Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors
Yixin Zhang et al.
PEPTIDES (2016)
Neurokinin-1 activation affects EGFR related signal transduction in triple negative breast cancer
Ji-Gang Wang et al.
CELLULAR SIGNALLING (2015)
Heterotrimeric G Proteins Directly Regulate MMP14/Membrane Type-1 Matrix Metalloprotease A NOVEL MECHANISM FOR GPCR-EGFR TRANSACTIVATION
Aaron C. Overland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer
Susana Garcia-Recio et al.
CANCER RESEARCH (2013)
Neurokinin-1 Receptor Directly Mediates Glioma Cell Migration by Up-regulation of Matrix Metalloproteinase-2 (MMP-2) and Membrane Type 1-Matrix Metalloproteinase (MT1-MMP)
Lingyun Mou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Divergent β-Arrestin-dependent Signaling Events Are Dependent upon Sequences within G-protein-coupled Receptor C Termini
Kasturi Pal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
Neil E. Bhola et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists
Miguel Munoz et al.
PEPTIDES (2012)
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation
Steven D. Douglas et al.
YEAR IN IMMUNOLOGY (2011)
EGFR Mutations and Lung Cancer
Gilda da Cunha Santos et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis
Prabhakara Reddy Nagareddy et al.
CARDIOVASCULAR RESEARCH (2009)
Involvement of Src Family Kinases in Substance P-Induced Chemokine Production in Mouse Pancreatic Acinar Cells and Its Significance in Acute Pancreatitis
Raina Devi Ramnath et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Wenjun Zhou et al.
NATURE (2009)
Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells
R Kodali et al.
CARDIOVASCULAR RESEARCH (2006)
Signal transduction through substance P receptor in human glioblastoma cells:: roles for Src and PKCδ
K Yamaguchi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model
RS Stearman et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Matrix metalloproteinases in reproductive endocrinology
BH Shah et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Metalloproteinases and transforming growth factor-α mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes
HW Koon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor
VWY Lui et al.
ONCOGENE (2003)
Transactivation joins multiple tracks to the ERK/MAPK cascade
R Wetzker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells
I Castagliuolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
